Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

PIG-L Inhibitors

PIG-L chemical inhibitiors like Tunicamycin and Kifunensine disrupt N-linked glycosylation and mannose trimming, respectively, which are steps crucial for the proper folding and function of many glycoproteins. By inhibiting these steps, these chemicals can lead to the accumulation of misfolded proteins and exert stress on the endoplasmic reticulum (ER), which could impact proteins that are reliant on these pathways for their maturation and function. Disruption of glycosylation can have widespread effects on cellular functions, potentially including the modulation of proteins like PIG-L.

Another aspect of PIG-L Inhibitors involves the disruption of intracellular transport and signaling pathways. Compounds such as Brefeldin A and Monensin interfere with protein trafficking between the ER and the Golgi apparatus, which is a critical pathway for the processing and sorting of secretory and membrane proteins. By inhibiting these pathways, the inhibitors might affect the proper localization and function of proteins that are dependent on ER-Golgi trafficking. On the level of cellular homeostasis and signaling, chemicals such as Thapsigargin and Cyclopiazonic Acid inhibit calcium pumps, leading to alterations in cytosolic calcium levels, which is a second messenger in many signaling pathways. These changes can have broad effects on cellular activities and potentially influence proteins associated with calcium signaling.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Swainsonine

72741-87-8sc-201362
sc-201362C
sc-201362A
sc-201362D
sc-201362B
1 mg
2 mg
5 mg
10 mg
25 mg
$138.00
$251.00
$631.00
$815.00
$1832.00
6
(1)

An inhibitor of Golgi alpha-mannosidase II, potentially affecting glycoprotein synthesis.

Decylubiquinone

55486-00-5sc-358659
sc-358659A
10 mg
50 mg
$70.00
$269.00
10
(2)

A ubiquinone analog that can inhibit mitochondrial electron transport, affecting cellular energetics.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

A fungal metabolite that inhibits protein transport from the ER to the Golgi apparatus.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

An inhibitor of N-linked glycosylation, which can disrupt protein folding and trafficking.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$155.00
$525.00
(1)

An ionophore that disrupts Golgi function, which could indirectly affect proteins processed in the Golgi.

Castanospermine

79831-76-8sc-201358
sc-201358A
100 mg
500 mg
$184.00
$632.00
10
(1)

An inhibitor of glucosidases, which may disrupt glycoprotein processing and maturation.

Deoxynojirimycin

19130-96-2sc-201369
sc-201369A
1 mg
5 mg
$73.00
$145.00
(0)

A glucosidase inhibitor that can alter glycosylation patterns and interfere with glycoprotein maturation.

Kifunensine

109944-15-2sc-201364
sc-201364A
sc-201364B
sc-201364C
1 mg
5 mg
10 mg
100 mg
$135.00
$540.00
$1025.00
$6248.00
25
(2)

An inhibitor of mannosidase I in the ER, potentially affecting N-glycan processing.

N-Butyldeoxynojirimycin·HCl

210110-90-0sc-201398
sc-201398A
sc-201398B
5 mg
25 mg
50 mg
$180.00
$550.00
$985.00
4
(1)

An iminosugar that inhibits glycosphingolipid biosynthesis, potentially affecting membrane composition.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

A GTPase inhibitor that can disrupt endocytosis and vesicular trafficking pathways.